Boditech Med Inc. (206640.KQ) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	165.8B	162.0B	138.2B	134.2B	118.1B
Cost of Revenue	68.8B	66.0B	56.4B	53.7B	50.7B
Gross Profit	97.0B	96.0B	81.8B	80.5B	67.4B
Operating Expenses
R&D Expense	19.6B	18.6B	16.0B	13.4B	14.7B
SG&A Expense	20.4B	20.2B	14.2B	33.6B	27.0B
General & Admin Expense	6.1B	5.9B	4.7B	4.1B	4.1B
Selling & Marketing Expense	14.3B	14.4B	9.5B	9.5B	6.8B
Other Expenses	32.2B	28.2B	25.5B	25.4B	2.4B
Total Operating Expenses	67.3B	67.0B	55.6B	47.1B	44.1B
Cost and Expenses	138.1B	133.1B	112.0B	100.8B	94.8B
Operating Income (EBIT)	27.7B	28.9B	26.2B	33.4B	23.3B
Non-Operating
Interest Income	4.2B	4.3B	1.0B	663.8M	332.2M
Interest Expense	4.4B	4.3B	352.5M	350.4M	203.9M
Net Interest Income	(248.8M)	(62.6M)	678.0M	313.4M	128.3M
Other Non-Op Income/Expense	3.4B	(1.1B)	6.3B	(1.9B)	3.6B
Non-Operating Income (excl Interest)	(19.1B)	748.3M	(6.6B)	5.2B	4.3B
EBT (Pre-Tax Income)	31.1B	27.8B	32.4B	31.6B	27.0B
Income Tax Expense	4.9B	3.9B	5.2B	4.9B	1.7B
Bottom Line
Net Income	26.0B	23.7B	27.3B	25.9B	24.2B
Earnings from Cont. Ops	26.1B	23.9B	27.2B	26.7B	25.3B
Earnings from Discont. Ops	—	—	—	—	(1.9K)
Bottom Line Net Income	26.0B	23.7B	27.3B	25.9B	24.2B
Per Share
Basic EPS	₩1,225	₩1,092	₩1,242	₩1,181	₩1,080
Diluted EPS	₩1,225	₩1,092	₩1,242	₩1,181	₩1,080
Revenue Per Share	₩8,061	₩7,473	₩6,297	₩6,110	₩5,280
Shares
Basic Shares Outstanding	20.6M	21.7M	21.9M	22.0M	22.4M
Diluted Shares Outstanding	20.6M	21.7M	21.9M	22.0M	22.4M
Profitability Metrics
EBITDA	42.4B	38.3B	41.2B	40.2B	35.0B
D&A	10.1B	10.1B	8.4B	8.2B	7.5B
EBIT	32.3B	28.2B	32.8B	31.9B	24.7B

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026